Credit Suisse’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $32.6M | Sell |
244,718
-11,372
| -4% | -$1.48M | 0.03% | 496 |
|
|
2023
Q4 | $35.3M | Sell |
256,090
-13,629
| -5% | -$1.79M | 0.03% | 483 |
|
|
2023
Q3 | $32.9M | Buy |
269,719
+9,386
| +4% | +$1.25M | 0.03% | 499 |
|
|
2023
Q2 | $36.6M | Sell |
260,333
-17,876
| -6% | -$2.46M | 0.04% | 486 |
|
|
2023
Q1 | $39.4M | Sell |
278,209
-26,620
| -9% | -$3.81M | 0.04% | 464 |
|
|
2022
Q4 | $47.7M | Buy |
304,829
+23,926
| +9% | +$3.44M | 0.05% | 411 |
|
|
2022
Q3 | $34.5M | Sell |
280,903
-25,150
| -8% | -$3.31M | 0.04% | 497 |
|
|
2022
Q2 | $40.7M | Sell |
306,053
-3,491
| -1% | -$476K | 0.04% | 459 |
|
|
2022
Q1 | $42.4M | Sell |
309,544
-96
| -0% | -$13.4K | 0.04% | 508 |
|
|
2021
Q4 | $53.6M | Sell |
309,640
-151,670
| -33% | -$23.1M | 0.03% | 605 |
|
|
2021
Q3 | $67M | Buy |
461,310
+18,256
| +4% | +$2.67M | 0.04% | 526 |
|
|
2021
Q2 | $58.9M | Buy |
443,054
+24,351
| +6% | +$3.19M | 0.03% | 599 |
|
|
2021
Q1 | $53.7M | Buy |
418,703
+88,384
| +27% | +$10.9M | 0.03% | 673 |
|
|
2020
Q4 | $39.4M | Buy |
330,319
+7,499
| +2% | +$914K | 0.02% | 819 |
|
|
2020
Q3 | $37M | Buy |
322,820
+16,396
| +5% | +$1.94M | 0.02% | 737 |
|
|
2020
Q2 | $34.9M | Sell |
306,424
-72,512
| -19% | -$7.69M | 0.03% | 694 |
|
|
2020
Q1 | $30.4M | Buy |
378,936
+21,179
| +6% | +$2.19M | 0.03% | 638 |
|
|
2019
Q4 | $38.2M | Buy |
357,757
+100,555
| +39% | +$10.5M | 0.03% | 692 |
|
|
2019
Q3 | $27.5M | Sell |
257,202
-59,276
| -19% | -$6.09M | 0.02% | 738 |
|
|
2019
Q2 | $32.2M | Buy |
316,478
+1,428
| +0.5% | +$137K | 0.03% | 660 |
|
|
2019
Q1 | $28.3M | Sell |
315,050
-12,980
| -4% | -$1.12M | 0.03% | 671 |
|
|
2018
Q4 | $27.3M | Buy |
328,030
+18,329
| +6% | +$1.72M | 0.03% | 626 |
|
|
2018
Q3 | $33.4M | Buy |
309,701
+86,298
| +39% | +$9.47M | 0.03% | 597 |
|
|
2018
Q2 | $24.6M | Sell |
223,403
-64,965
| -23% | -$6.77M | 0.02% | 727 |
|
|
2018
Q1 | $28.9M | Buy |
288,368
+14,487
| +5% | +$1.48M | 0.03% | 659 |
|
|
2017
Q4 | $27M | Sell |
273,881
-38,017
| -12% | -$3.6M | 0.02% | 729 |
|
|
2017
Q3 | $29.2M | Buy |
311,898
+7,536
| +2% | +$800K | 0.03% | 629 |
|
|
2017
Q2 | $33.8M | Buy |
304,362
+24,179
| +9% | +$2.56M | 0.03% | 551 |
|
|
2017
Q1 | $27.5M | Buy |
280,183
+409
| +0.1% | +$39K | 0.02% | 669 |
|
|
2016
Q4 | $25.7M | Sell |
279,774
-284,302
| -50% | -$24.5M | 0.03% | 674 |
|
|
2016
Q3 | $47.7M | Buy |
564,076
+358,923
| +175% | +$30.1M | 0.05% | 451 |
|
|
2016
Q2 | $16.7M | Buy |
205,153
+26,028
| +15% | +$1.98M | 0.02% | 868 |
|
|
2016
Q1 | $12.8M | Sell |
179,125
-51,082
| -22% | -$3.43M | 0.02% | 969 |
|
|
2015
Q4 | $16.4M | Sell |
230,207
-11,632
| -5% | -$782K | 0.02% | 884 |
|
|
2015
Q3 | $14.9M | Sell |
241,839
-86,897
| -26% | -$6.07M | 0.02% | 905 |
|
|
2015
Q2 | $23.8M | Sell |
328,736
-109,499
| -25% | -$8.08M | 0.02% | 744 |
|
|
2015
Q1 | $33.7M | Buy |
438,235
+106,658
| +32% | +$7.64M | 0.03% | 575 |
|
|
2014
Q4 | $22.2M | Buy |
331,577
+7,926
| +2% | +$500K | 0.02% | 827 |
|
|
2014
Q3 | $19.6M | Sell |
323,651
-153,835
| -32% | -$9.48M | 0.02% | 922 |
|
|
2014
Q2 | $28M | Sell |
477,486
-49,340
| -9% | -$2.89M | 0.02% | 746 |
|
|
2014
Q1 | $30.5M | Sell |
526,826
-42,921
| -8% | -$2.3M | 0.03% | 627 |
|
|
2013
Q4 | $30.5M | Buy |
569,747
+130,527
| +30% | +$7.74M | 0.03% | 617 |
|
|
2013
Q3 | $27.1M | Sell |
439,220
-41,421
| -9% | -$2.48M | 0.03% | 591 |
|
|
2013
Q2 | $29.1M | Buy |
+480,641
| New | +$28.6M | 0.03% | 580 |
|
Other funds holding DGX
DSA
Credit Suisse's DGX Position: Q1 2024 in Review
Credit Suisse reduced its Quest Diagnostics (DGX) stake by 4.4% in Q1 2024, selling an estimated $1.48M and leaving 244,718 shares worth $32.6M. The position accounts for 0.03% of the portfolio, ranked #496.
Credit Suisse first reported a position in DGX in Q2 2013 and has held it in 44 quarters since. The position peaked at $67M in Q3 2021. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2024.
- Credit Suisse held 244,718 shares of Quest Diagnostics worth $32.6M as of Q1 2024.
- Credit Suisse sold 11,372 Quest Diagnostics shares in Q1 2024, an estimated $1.48M.
- Quest Diagnostics made up 0.03% of Credit Suisse's portfolio in Q1 2024, its #496 holding.
- Credit Suisse first reported a position in Quest Diagnostics in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Quest Diagnostics position peaked at $67M in Q3 2021.
- 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.